During the past decade, James P. Wilmot Cancer Center at University of Rochester Medical Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 82 clinical trials were completed, i.e. on average, 911.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 14 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "James P. Wilmot Cancer Center at University of Rochester Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 71 trials, followed by "Children's Oncology Group" with 37 trials sponsored, "Radiation Therapy Oncology Group" with 31 trials sponsored, "Alliance for Clinical Trials in Oncology" with 21 trials sponsored and "University of Rochester" with 21 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "James P. Wilmot Cancer Center at University of Rochester Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 182 trials as a collaborator, "NRG Oncology" with 20 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "SWOG Cancer Research Network" with 9 trials as a collaborator and "NCIC Clinical Trials Group" with 7 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "James P. Wilmot Cancer Center at University of Rochester Medical Center" are "Lymphoma" (30 trials), "Lung Cancer" (29 trials), "Leukemia" (27 trials), "Breast Cancer" (22 trials) and "Prostate Cancer" (19 trials). Many other conditions were trialed in "James P. Wilmot Cancer Center at University of Rochester Medical Center" in a lesser frequency.

Most popular intervention types in "James P. Wilmot Cancer Center at University of Rochester Medical Center" are "Drug" (159 trials), "Radiation" (73 trials), "Biological" (63 trials), "Procedure" (53 trials) and "Other" (24 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (40 trials), "cyclophosphamide" (38 trials), "filgrastim" (26 trials), "doxorubicin hydrochloride" (20 trials) and "vincristine sulfate" (20 trials). Other intervention names were less common.

The vast majority of trials in "James P. Wilmot Cancer Center at University of Rochester Medical Center" are 171 trials for "All" genders, 22 trials for "Female" genders and 19 trials for "Male" genders.

Currently, there are NaN active trials in "James P. Wilmot Cancer Center at University of Rochester Medical Center". undefined are not yet recruiting, 3 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 166 completed trials in James P. Wilmot Cancer Center at University of Rochester Medical Center, undefined suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in James P. Wilmot Cancer Center at University of Rochester Medical Center, 16 "Phase 1" clinical trials were conducted, 98 "Phase 2" clinical trials and 76 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 15 trials that are defined as “Not Applicable".